Allan-Herndon-Dudley Syndrome
|
111.07 B
See DI 23022.925.
|
Aplastic Anemia
|
7.17 or 107.17
See DI 23022.929.
|
Multiple System Atrophy
|
11.04 or 12.02
See DI 23022.630.
|
Breast Cancer
|
13.10 A
See DI 23022.125.
|
Canavan Disease
|
110.08 B
See DI 23022.130.
|
Cardiac Amyloidosis—AL Type
|
4.02 or 4.05
See DI 23022.580.
|
Congenital Lymphedema
|
101.21
See DI 23022.939.
|
Mixed Dementia
|
12.02, 11.04, 11.06, or 11.17
See DI 23022.455.
|
Esthesioneuroblastoma
|
13.13 B1
See DI 23022.156.
|
Farber’s Disease
|
114.09 A, 114.09 B, or 114.09 D
See DI 23022.160.
|
Giant Axonal Neuropathy
|
111.02 or 112.02
See DI 23022.181.
|
Hemophagocytic Lymphohistiocytosis
|
114.07 A, 114.07 B, or 114.07 C
See DI 23022.405.
|
Hypocomplementemic Urticarial Vasculitis Syndrome
|
3.02 A
See DI 23022.765.
|
Idiopathic Pulmonary Fibrosis
|
3.02 A, 3.02 B, 3.02 C, or 3.09
See DI 23022.420.
|
Joubert Syndrome
|
112.02
See DI 23022.202.
|
Kufs Disease—Type B
|
11.04 or 11.06
See DI 23022.790.
|
Leptomeningeal Carcinomatosis
|
13.13 A
See DI 23022.216.
|
Lewy Body Dementia
|
11.04 or 11.06
See DI 23022.610.
|
Lymphomatoid Granulomatosis – Grade III
|
13.13 A1 or 113.13
See DI 23022.800.
|
Malignant Brain Stem Gliomas—Childhood
|
13.13 A2
See DI 23022.805.
|
Malignant Ectomesenchymoma
|
13.13 A2
See DI 23022.226.
|
Malignant Gastrointestinal Stromal Tumor
|
13.16 B2
See DI 23022.963.
|
Marshall-Smith Syndrome
|
2.09
See DI 23022.231.
|
Merkel Cell Carcinoma—with metastasis
|
13.03 A
See DI 23022.825.
|
Myoclonic Epilepsy with Ragged Red Fibers Syndrome
|
11.17 or 12.02
See DI 23022.830.
|
Nephrogenic Systemic Fibrosis
|
1.18, 6.02 C, or 14.04 B
See DI 23022.835.
|
Neurodegeneration with Brain Iron Accumulation—Type 1 and 2
|
11.06
See DI 23022.836.
|
Ovarian Cancer
|
13.23 E1a
See DI 23022.260.
|
Pearson Syndrome
|
107.03
See DI 23022.855.
|
Pelizaeus-Merzbacher Disease—Classic Form
|
11.06
See DI 23022.860.
|
Peritoneal Mesothelioma
|
13.16
See DI 23022.270.
|
Peritoneal Mucinous Carcinomatosis
|
13.15 B or 13.23 E1
See DI 23022.975.
|
Primary Progressive Aphasia
|
11.04 A
See DI 23022.485.
|
Progressive Supranuclear Palsy
|
11.06
See DI 23022.650.
|
Revesz Syndrome
|
7.17, 107.03 or 110.08 B
See DI 23022.286.
|
Salivary Cancers
|
13.14 B
See DI 23022.290.
|
Sanfilippo Syndrome
|
110.08 B
See DI 23022.495.
|
Small Cell Cancer of the Thymus
|
13.14 B
See DI 23022.290.
|
Stiff Person Syndrome
|
11.06
See DI 23022.905.
|
Spinal Muscular Atrophy (SMA) - Types 0 and 1
|
111.22
See DI 23022.330.
|
Tabes Dorsalis
|
11.08 or 11.17
See DI 23022.910.
|
Ventricular Assist Device Recipient—Left, Right, or Biventricular
|
4.09 or 104.09
See DI 23022.570.
|
X-Linked Myotubular Myopathy
|
3.02 B, 3.04 B, 3.07 or 5.07
See DI 23022.347.
|